Recalculate this Equation

Progress in many research areas is limited by funding constraints, so budgets must always be subjected to thorough scrutiny. However, we must be equally thorough in examining research costs regarding the anticipated benefits of that research. For example, if we apply this to Professor Potts' remarks about the high costs of clinical trials of microbicides,1 it is clear that he has presented only one side of the equation. Yes, costs are high. For a Phase III trial of a microbicide, we must budget

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Progress in many research areas is limited by funding constraints, so budgets must always be subjected to thorough scrutiny. However, we must be equally thorough in examining research costs regarding the anticipated benefits of that research. For example, if we apply this to Professor Potts' remarks about the high costs of clinical trials of microbicides,1 it is clear that he has presented only one side of the equation. Yes, costs are high. For a Phase III trial of a microbicide, we must budget about $3,000–5,000 annually per participant for follow-up, and there will be several thousand participants. So the trial may cost up to $20–40 million. But it's not a matter of "when expenses such as these are spelled out." They have been, and researchers agonize about ways to economize. If "costs can frame ethics," then the reverse is also true: a considerable proportion of the trials' costs flows from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Alan Stone

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio